Treatment with Rituximab in Benign and Malignant Hematologic Disorders in Children
To access this article, please choose from the options below
PII: S0022-3476(06)01204-2
doi:10.1016/j.jpeds.2006.12.038
© 2007 Mosby, Inc. All rights reserved.
PII: S0022-3476(06)01204-2
doi:10.1016/j.jpeds.2006.12.038
© 2007 Mosby, Inc. All rights reserved.